Publication date: Available online 7 February 2018
Source:International Journal of Pediatric Otorhinolaryngology
Author(s): Faisal Zawawi, Meirav Sokolov, Thomas Mawby, Karen A. Gordon, Blake C. Papsin, Sharon L. Cushing
Emberger Syndrome (ES) is a rare genetic disorder characterized by lymphedema and myelodysplasia. It is also associated with hearing loss. The genetic mutations associated with ES are not part of the comprehensive 80 gene next generation sequencing (NGS) panel. As a result, the otolaryngologist should maintain an index of suspicion for ES in any child with SNHL who presents repeatedly with recurrent infections, lymphedema and/or cutaneous warts. This paper describes the clinical evolution and management of two children who were followed up for hearing loss and eventually were diagnosed with ES.
from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2nVZQvq
via IFTTT
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
A two-arm multicenter phase II trial of one cycle chemoselection split-dose docetaxel, cisplatin and 5-fluorouracil (TPF) induction che...
-
Abstract Purpose Overcoming the flaws of current data management conditions in head and neck oncology could enable integrated informatio...
-
Differential Evolution Optimization of the SAR Distribution for Head and Neck Hyperthermia. IEEE Trans Biomed Eng. 2016 Nov 14;: Auth...
-
This paper investigates the control and synchronization of a class of chaotic systems with switched output which is assumed to be switched b...
-
RT @ecancer_espanol : Abiraterone for metastatic, hormone sensitive, prostate cancer https://t.co/xa9jVlFrCg https://t.co/dj5XAacWCF fro...
-
Melanocyte development is orchestrated by a complex interconnecting regulatory network of genes and synergistic interactions. Piebaldism and...
-
Abstract Hepatocarcinogenesis is a multi-step process characterized by progressive cellular and molecular dedifferentiation of hepatocytes ...
-
Purpose: 18 F-fluoroestradiol (FES) PET scans measure regional estrogen binding, and 18 F-fluorodeoxyglucose (FDG) PET measures tumor glycol...
-
Publication date: 1 August 2017 Source: Cancer Letters, Volume 400 Author(s): Amr S. Abu Lila, Naoto Moriyoshi, Masakazu Fukushima, Cheng-...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου